Predictmedix AI Inc. (CSE: PMED)
Canada
· Delayed Price · Currency is CAD 0.0100
-0.0050 (-33.33%)
Nov 20, 2024, 11:45 AM EST
Predictmedix AI Income Statement
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 |
| Revenue | - | - | 0.04 | 0.13 | - | - | Upgrade
|
| Revenue Growth (YoY) | - | - | -74.02% | - | - | - | Upgrade
|
| Cost of Revenue | - | - | 0.01 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Gross Profit | - | - | 0.03 | 0.08 | -0.01 | -0.01 | Upgrade
|
| Selling, General & Admin | 1.14 | 1.65 | 1.38 | 1.48 | 0.88 | 0.67 | Upgrade
|
| Research & Development | - | - | 0.08 | 0.07 | 0.03 | 0.07 | Upgrade
|
| Operating Expenses | 1.3 | 1.91 | 1.97 | 1.82 | 1.86 | 0.75 | Upgrade
|
| Operating Income | -1.3 | -1.91 | -1.95 | -1.73 | -1.87 | -0.76 | Upgrade
|
| Interest Expense | - | -0.01 | -0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | -0.07 | -0.12 | -0.15 | -0.06 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -1.35 | -1.99 | -2.07 | -1.88 | -1.93 | -0.78 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -1.49 | Upgrade
|
| Pretax Income | -1.35 | -1.99 | -2.07 | -1.88 | -1.93 | -2.27 | Upgrade
|
| Earnings From Continuing Operations | -1.35 | -1.99 | -2.07 | -1.88 | -1.93 | -2.27 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 0.35 | -0.04 | Upgrade
|
| Net Income to Company | -1.35 | -1.99 | -2.07 | -1.88 | -1.58 | -2.31 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0 | 0.02 | Upgrade
|
| Net Income | -1.35 | -1.99 | -2.07 | -1.88 | -1.58 | -2.29 | Upgrade
|
| Net Income to Common | -1.35 | -1.99 | -2.07 | -1.88 | -1.58 | -2.29 | Upgrade
|
| Shares Outstanding (Basic) | 150 | 143 | 114 | 108 | 101 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 143 | 114 | 108 | 101 | 98 | Upgrade
|
| Shares Change (YoY) | 16.99% | 25.19% | 5.78% | 6.65% | 3.45% | 70.51% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Free Cash Flow | -0.21 | -1.64 | -0.63 | -1.62 | -1.08 | -0.85 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | - | - | 76.01% | 62.91% | - | - | Upgrade
|
| Operating Margin | - | - | -5560.75% | -1284.40% | - | - | Upgrade
|
| Profit Margin | - | - | -5904.50% | -1396.07% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -1796.12% | -1199.38% | - | - | Upgrade
|
| EBITDA | -1.33 | -1.87 | -1.91 | -1.71 | -1.87 | -0.76 | Upgrade
|
| D&A For EBITDA | -0.03 | 0.04 | 0.04 | 0.02 | 0 | 0 | Upgrade
|
| EBIT | -1.3 | -1.91 | -1.95 | -1.73 | -1.87 | -0.76 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.